Related Experiment Videos
Left ventriculoplasty for nonischemic dilated cardiomyopathy
H Suma1,
1Hayama Heart Center, Kanagawa, Japan.
Insights
Surgical ventricular reconstruction for nonischemic dilated cardiomyopathy shows promise. Refined techniques may offer an alternative to heart transplantation for heart failure patients.
Area of Science:
- Cardiovascular Surgery
- Heart Failure Management
- Cardiac Remodeling
Background:
- Nonischemic dilated cardiomyopathy (DCM) presents a significant challenge, often necessitating heart transplantation.
- Current pharmacologic therapies improve survival but do not fully address the needs of all patients.
- A shortage of donor hearts drives the demand for effective, non-transplant surgical options.
Purpose of the Study:
- To explore the potential of surgical ventricular reconstruction as a treatment for nonischemic DCM.
- To evaluate the feasibility and outcomes of partial left ventriculectomy (PLV) and ventriculoplasty.
- To identify strategies for improving the efficacy and safety of these surgical interventions.
Main Methods:
- Review of existing literature and case studies on surgical ventricular reconstruction for nonischemic DCM.
- Analysis of outcomes associated with partial left ventriculectomy (PLV), including surgical mortality and late functional recovery.
- Exploration of patient selection criteria and surgical modifications for ventriculoplasty.
Main Results:
- Partial left ventriculectomy (PLV) initially showed promise but faced challenges with high surgical mortality and recurrent heart failure.
- Despite limitations, some cases demonstrated improved clinical status and ventricular function post-PLV.
- Ventriculoplasty techniques are being refined to enhance outcomes.
Conclusions:
- Surgical ventricular reconstruction, particularly ventriculoplasty, holds potential for treating heart failure in nonischemic DCM.
- Improved patient selection and surgical modifications are crucial for the success of ventriculoplasty.
- Further research and refinement are needed to establish ventriculoplasty as a standard, safe, and effective treatment option.
Abstract:
Surgical treatment of nonischemic dilated cardiomyopathy is a new field in cardiac surgery. Although current pharmacologic therapy has shown improved survival rates, many patients still need heart transplantation. To reduce the shortage of donors, there is a demanding need for effective nontransplant cardiac surgery. In the past 5 years, partial left ventriculectomy (PLV) has emerged with initial enthusiasm, but is not used because of high surgical mortality and late return of heart failure. There are several examples of improved clinical status and ventricular function with the procedure. By refining patient selection and surgical modification, ventriculoplasty will become a realistic option in the treatment of heart failure caused by nonischemic cardiomyopathy.